Personalized Flu Shots Offer Best Chance to Beat Season - Bloomberg
Personalized Flu Shots Offer Best Chance to Beat Season
By Michelle Fay Cortez
A wave of new flu vaccines designed for the first time to focus on individual groups, including children, the elderly and people with allergies, may help boost U.S. vaccination rates as the new season develops this year.
Traditionally, less than half of Americans get vaccinated. Now, in a banner year, the Food and Drug Administration has approved three new vaccines for the nascent flu season that will bring the concept of personalized medicine to the yearly effort to control influenza, the nation’s eighth-biggest killer.
The new treatments join 10 others available for the 2013-2014 season, from companies including AstraZeneca Plc (AZN), Novartis AG (NOVN), GlaxoSmithKline Plc (GSK) and CSL Ltd. (CSL) Facing an early start to this year’s season, health officials are seeking to beat the 45 percent vaccination rate achieved last year, when 1 of every 500 people older than 65 was hospitalized with the flu.
To read the full article go to: http://www.bloomberg.com/news/2013-12-04/personalized-flu-shots-offer-best-chance-to-beat-season